HIV Infection & AIDS: Clinical

BIOGRAPHY

Dr. Mark A. Wainberg is Director of the McGill University AIDS Centre and Professor of Medicine and of Microbiology at McGill University in Montreal, Canada. Dr. Wainberg is an internationally recognized scientist in the field of HIV/AIDS, who has made important independent contributions to the study of anti-viral drug development and HIV drug resistance. He served as President of the International AIDS Society between 1998-2000.

He is well known for his initial identification of 3TC as an anti-viral drug, in collaboration with BioChem Pharma Inc in 1989. His laboratory continues to work in these areas and, as well, Dr. Wainberg has now turned his attention to novel concepts in HIV vaccine development and prevention of HIV infection. He is a strong advocate of measures that will enhance prevention of HIV infection in developing countries. He will be the Co-Chair of the XVI International AIDS Conference, that will take place in Toronto during the summer of 2006. Dr. Wainberg is a member of the Royal Society of Canada and an Officer of the Order of Canada. He is also an Officer of the Order National of Québec.